Abstract: The present invention relates to a veterinary anti-prolactin composition to be administered to ruminants. Said composition includes at least one anti-prolactin compound which is an agonist for dopamine receptors and which is particularly useful for preventing and/or reducing the harmful effects in ruminants linked to use for a shortened dry period. Said composition is particularly useful for preventing and/or reducing metabolic diseases and/or reproductive disorders when lactation is resumed.

Abstract: Disclosed herein is a method for positioning a tip of a needle for injection into and/or removal from an egg. The method includes steps of: measuring at least one electrical parameter characteristic of a target zone to obtain a reference electrical value; measuring the electrical parameter at the tip to obtain a value measured at a position of the tip in the egg; and comparing the measured value with a characteristic reference parameter. A system for determining a position of a tip of a needle for injection into and/or removal from an egg is also disclosed.

Abstract: This present invention relates to an antiprolactinic veterinary composition to be administered to ruminants. Said composition comprises at least one antiprolactinic compound which is an agonist of dopamine receptors, and is particularly useful for reducing udder engorgement and/or the reduction of pain after drying off and/or of increasing welfare, and/or of reducing milk leakage in ruminants as well as for preventing new mammary microbial infections, secondary infection, or co-infections in ruminants and mastitis.

Abstract: The present invention relates to ivermectin formulations for administration to pet and domestic animals. These formulations provide long term protection against Dirofilaria parasites, without the risks for secondary adverse of conventional formulations. Preferred formulations are collars, collar strips, or medallions, attachments for collars, ear tags, bands which are affixed to limbs or parts of the body, adhesive strips and films, and peel-off films, or spot-on or pour-on forms which are administered at least twice a year up to around once a year.

Abstract: The present invention further relates to ivermectin, most preferably formulated as an implant for administration of pet and domestic animals. These formulations provide long term protection against Dirofilaria parasites, without the risks for secondary adverse events of conventional formulations. Preferred formulations are implants and are administered at least twice a year, once a year, or at least once in 18 months, up to 24 months.

Abstract: The present invention relates to an automatic egg examining device for differentiating between fertilized eggs and unfertilized eggs, comprising emission means (3), which comprise, for each egg to be examined, at least one coherent laser source forming a coherent optical beam (31) directed at an egg (9) to be examined, reception means (4), which receive the light flux passing through the egg, and data processing means (7), which process the light flux received by said reception means in order to determine the state—fertilized or unfertilized—of the egg.

Abstract: An injector for injecting at least one substance into eggs, comprising an injection body that can be moved between a raised position and an injection position, and equipped with an injection conduit, an injection needle, a guiding and protection tube of the needle subject to elastic stress by elastic means to an idle position and capable of being moved towards a retracted position by pressing its distal end against an egg when the injector is in the injection position. The injector is equipped with control means for controlling the supply of said injection conduit with at least one substance, said tube cooperating with said control means to disable the supply of said injection conduit when said tube is in the idle position and to enable the supply of said conduit when said tube is in the retracted position.

Abstract: Method and device for injecting at least one product in an egg for treating the embryo. The method includes perforating a shell and an outer shell membrane on a large end of the egg, and injecting the product into an air chamber of the egg under pressure sufficient for the product to reach the amniotic fluid after passing with pressure through an inner shell membrane.

Abstract: The present invention relates to the novel Porcine Circovirus type 2 subtype B (PCV2B-Rm) isolate which comprises a short duplication of sequence and is adapted to grow in cell culture and may be propagated at high titres constantly up to 106 TCID50 viral particles per mL. This novel isolate is particularly useful for the production of porcine circovirus type 2 (PCV2) vaccines, for treating and/or preventing and/or diagnosing porcine circovirus associated diseases, as well as for diagnosing the presence of porcine circovirus in pigs. The present invention also relates to novel cell clones derived from Swine Testicles (ST) useful for propagating PCV2 and to a method for production of PCV2 virus with particularly high titers.

Abstract: This present invention relates to an antiprolactinic veterinary composition to be administered to ruminants. Said composition comprises at least one antiprolactinic compound which is an agonist of dopamine receptors, and is particularly useful for promoting a substantial reduction of lactation, mammary involution, and for treating and/or intra-mammary diseases or infections of ruminants.

Abstract: The invention relates to vaccine compositions comprising chitosan and a vaccine which are administered to avian species via the ocular route, and methods or programs of vaccination including use of chitosan in order to increase or enhance cell-mediated immunity in avian species and persistence of the vaccine avian tissues.

Abstract: This invention describes a new topical formulation (spot-on) for controlling ectoparasites in cats and dogs, which comprises the active ingredient Fipronil and/or the derivates and salts thereof, as well as antioxidants and a suitable vehicle. The use of an organic solvent acting as the transdermal carrier provides this product with a longer residual period and, consequently, higher efficacy.

Abstract: Mixture of fatty acids, their derivatives, ester or methyl ester derivates thereof, which may be administered to non-human mammals by diffusion in to ambient air during at least seven consecutive days, with a rapid kinetic of diffusion during the first three days of administration.

Abstract: The invention relates to a process for treating lameness with an osseous, articular or osteoarticular component, comprising the administration, to a human or to an animal not suffering from arthritis or from fractures, of an effective amount of a bisphosphonic acid derivative of formula: in which: R1 represents a hydrogen atom, a halogen atom, a hydroxyl, an amino, a mono(C1-C4)alkylamino or a di(C1-C4) alkylamino; R2 represents a halogen atom, a linear alkyl comprising from 1 to 5 carbon atoms which is unsubstituted or substituted with a group chosen from a chlorine atom, a hydroxyl, an amino, a mono(C1-C4)alkylamino or a di(C1-C4)alkylamino; a (C3-C7) cycloalkylamino, or R2 represents a phenoxy, a phenyl, a thiol, a phenylthio, a chlorophenylthio, a pyridyl, a pyridyl-methyl, a 1-pyridyl-1-hydroxymethyl, an imidazolyl-methyl or a 4-thiomorpholinyl, of one of its pharmaceutically acceptable salts or of one of its hydrates.

Abstract: The invention relates to novel compositions including an aldosterone antagonist and administered according to a predetermined dosage for treating heart deficiency in non-human mammals.

Abstract: Multi-layered plastic polymeric container useful for the storage and conservation of pharmaceutical compositions, sterile or non sterile, which comprises an inner layer and an outer layer, a gas barrier layer, and adhesive layers.

Abstract: The present invention relates to an automatic egg examining device for differentiating between fertilized eggs and unfertilized eggs, comprising emission means (3), which comprise, for each egg to be examined, at least one coherent laser source forming a coherent optical beam (31) directed at an egg (9) to be examined, reception means (4), which receive the light flux passing through the egg, and data processing means (7), which process the light flux received by said reception means in order to determine the state—fertilized or unfertilized—of the egg.

Abstract: An injector for injecting at least one substance into eggs, comprising an injection body that can be moved between a raised position and an injection position, and equipped with an injection conduit, an injection needle, a guiding and protection tube of the needle subject to elastic stress by elastic means to an idle position and capable of being moved towards a retracted position by pressing its distal end against an egg when the injector is in the injection position. The injector is equipped with control means for controlling the supply of said injection conduit with at least one substance, said tube cooperating with said control means to disable the supply of said injection conduit when said tube is in the idle position and to enable the supply of said conduit when said tube is in the retracted position.

Abstract: The invention relates to new compositions comprising an aldosterone antagonist according to a particular posology for the treatment of heart failure in non-human mammal animals.